CRISAFULLI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.526
AS - Asia 1.036
EU - Europa 752
SA - Sud America 152
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 22
AN - Antartide 1
Totale 3.540
Nazione #
US - Stati Uniti d'America 1.478
SG - Singapore 413
IT - Italia 329
CN - Cina 224
HK - Hong Kong 128
BR - Brasile 121
DE - Germania 92
BD - Bangladesh 74
VN - Vietnam 74
FI - Finlandia 59
FR - Francia 47
GB - Regno Unito 43
TR - Turchia 35
RU - Federazione Russa 30
UA - Ucraina 29
IE - Irlanda 24
CA - Canada 23
NL - Olanda 18
IN - India 17
PL - Polonia 16
MX - Messico 14
IQ - Iraq 12
ZA - Sudafrica 11
SE - Svezia 10
AR - Argentina 9
AT - Austria 9
ES - Italia 9
ID - Indonesia 9
JP - Giappone 9
SA - Arabia Saudita 8
MK - Macedonia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
CO - Colombia 5
EC - Ecuador 5
EG - Egitto 5
GR - Grecia 5
JM - Giamaica 5
AL - Albania 4
LB - Libano 4
UZ - Uzbekistan 4
CR - Costa Rica 3
LT - Lituania 3
PH - Filippine 3
PK - Pakistan 3
AZ - Azerbaigian 2
CH - Svizzera 2
DZ - Algeria 2
KZ - Kazakistan 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
Totale 3.489
Città #
Singapore 250
Ashburn 176
San Jose 173
Hong Kong 128
Fairfield 82
Dallas 75
New York 73
The Dalles 58
Beijing 52
Munich 45
Los Angeles 43
Chandler 41
Council Bluffs 41
Houston 41
Helsinki 37
Columbus 35
Princeton 34
Milan 32
Seattle 31
Wilmington 29
Rome 28
Istanbul 27
Lauterbourg 27
Brescia 26
Woodbridge 26
Ho Chi Minh City 25
Cambridge 24
Dublin 24
Jacksonville 22
Turku 19
Buffalo 17
Palermo 17
Shanghai 17
Santa Clara 16
San Francisco 15
Ann Arbor 14
Chicago 14
Hanoi 13
Redondo Beach 13
Warsaw 13
Denver 12
Atlanta 10
Turin 10
Frankfurt am Main 9
Moscow 8
San Diego 8
São Paulo 8
Johannesburg 7
London 7
Tianjin 7
Tokyo 7
Toronto 7
Amsterdam 6
Des Moines 6
Nuremberg 6
Phoenix 6
Poplar 6
Bergamo 5
Boardman 5
Catania 5
Changsha 5
Chennai 5
Crotone 5
Haiphong 5
Kingston 5
Orem 5
Alexandria 4
Bologna 4
Bosio 4
Dosso 4
Erbil 4
Fortaleza 4
Jinan 4
Kolkata 4
Manchester 4
Mexico City 4
Montreal 4
Naples 4
Ottawa 4
Padova 4
Paris 4
Rio de Janeiro 4
Romola 4
Tashkent 4
Vienna 4
Belo Horizonte 3
Biên Hòa 3
Brno 3
Cape Town 3
Castelli Calepio 3
Desenzano del Garda 3
Duncan 3
Florence 3
Genoa 3
Goiânia 3
Lappeenranta 3
Messina 3
Nanjing 3
Newark 3
Orlando 3
Totale 2.169
Nome #
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 221
SALUTE RIPRODUTTIVA NELLE PAZIENTI CON MALATTIE REUMATOLOGICHE SEGUITE PROSPETTICAMENTE DA TEAM MULTIDISCIPLINARI: ANALISI DELL’OUTCOME MATERNO-FETALE, VALUTAZIONE DELLA TERAPIA IN GRAVIDANZA E IDENTIFICAZIONE DI FATTORI DI RISCHIO PER EVENTI AVVERSI 197
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 174
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study 160
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 134
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease 127
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 127
Does seronegative obstetric APS exist? “pro” and “cons” 118
Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers 117
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 116
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 112
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 112
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 106
Pregnancy and reproductive aspects of systemic lupus erythematosus 106
Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes 105
Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study 103
Managing puerperium in patients with systemic autoimmune diseases: an update 101
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 95
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 87
Pregnancy in patients affected by axial-spondyloarthritis: a narrative review of disease activity and obstetric outcomes 85
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 84
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 79
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 78
Retention rate of IL-1 inhibitors in Schnitzler's syndrome 74
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 70
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 69
Women of childbearing age living with spondyloarthritis: time for improving knowledge and counselling about reproductive issues 68
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 66
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study) 64
Complement levels during the first trimester predict disease flare and adverse pregnancy outcomes in systemic lupus erythematosus: A network meta-analysis on 532 pregnancies 62
Reproductive Health in Scleroderma, Vasculitis, and Sjögren Syndrome 62
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 60
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 45
The use of tumor necrosis factor inhibitors during high-risk pregnancies in antiphospholipid syndrome: a clinical report of a patient with concomitant Takayasu arteritis and case-based review 34
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus 28
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel 24
The Italian Society for Rheumatology guidelines on reproductive health in patients with rheumatic diseases 13
Risk of major organ involvement in Behçet’s patients with mucocutaneous onset: data from the AIDA Network Registry 9
Monoclonal Antibodies in Pregnancy of Patients with Systemic Lupus Erythematosus: Friend or Foe? A Case Report of a Patient with Multiple Pregnancies 9
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network. 7
Development and validation of a Relapsing Polychondritis disease-specific Quality of Life instrument (ERN ReCONNET RP-QoL) 7
The Risk of Developing Ocular Involvement Among Behçet’s Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet’s Disease Registry 7
European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT) 6
Identifying quality of life domains and facets affected in relapsing polychondritis: a qualitative analysis for the development of a disease-specific health-related quality of life instrument 6
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries 6
Totale 3.540
Categoria #
all - tutte 19.401
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.401


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022153 0 23 12 7 5 13 6 8 10 20 16 33
2022/2023138 22 7 2 2 14 39 5 10 23 1 7 6
2023/2024269 19 2 23 15 7 45 13 17 52 22 12 42
2024/2025720 15 13 23 78 81 69 53 43 66 50 143 86
2025/20261.749 132 161 151 193 170 125 256 84 112 180 123 62
2026/2027162 117 45 0 0 0 0 0 0 0 0 0 0
Totale 3.540